Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kadri Altundag

Showing results (141-150 of 151) with videos related to

Pageof 16
Sort By:
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 28, 2014
Impact of inflammatory markers on the prognosis of patients with operable breast cancerIbrahim Petekkaya, Sercan Aksoy, Emir C Roach, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|July 22, 2017
Prognostic role of inflammatory biomarkers in metastatic breast cancerIbrahim Petekkaya, Ozan Unlu, Emir C Roach, et al.
Breast Cancer Research : BCR|December 19, 2007
CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancerFrancisco J Esteva, Jing Wang, Feng Lin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 6, 2012
Stem cell-related markers in primary breast cancers and associated metastatic lesionsGulnur Guler, Serdar Balci, Stefan Costinean, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|May 24, 2017
Comparative study of receptor discordance between primary and corresponding metastatic lesions in breast cancerGokmen U Erdem, Kadri Altundag, Nuriye Y Ozdemir, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 30, 2016
Correlation of educational status and clinicopathological characteristics of breast cancer: a single center experienceFurkan Sarici, Taner Babacan, Hakan Buyukhatipoglu, et al.
Tumori|May 9, 2015
Efficacy of capecitabine monotherapy as the first-line treatment of metastatic HER2-negative breast cancerTaner Babacan, Orhan Efe, Ahmet S Hasirci, et al.
Journal of the National Medical Association|May 30, 2008
Characteristics of breast cancer patients with central nervous system metastases: a single-center experienceHakan Harputluoglu, Omer Dizdar, Sercan Aksoy, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|December 24, 2014
Outcome of 561 non-metastatic triple negative breast cancer patients: multi-center experience from TurkeyBurcin Budakoglu, Kadri Altundag, Sercan Aksoy, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 19, 2008
Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonatesAna O Hoff, Béla B Toth, Kadri Altundag, et al.
Pageof 16

Showing results (141-150 of 151) with videos related to

Sort By:
Pageof 16
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 28, 2014
Impact of inflammatory markers on the prognosis of patients with operable breast cancerIbrahim Petekkaya, Sercan Aksoy, Emir C Roach, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|July 22, 2017
Prognostic role of inflammatory biomarkers in metastatic breast cancerIbrahim Petekkaya, Ozan Unlu, Emir C Roach, et al.
Breast Cancer Research : BCR|December 19, 2007
CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancerFrancisco J Esteva, Jing Wang, Feng Lin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 6, 2012
Stem cell-related markers in primary breast cancers and associated metastatic lesionsGulnur Guler, Serdar Balci, Stefan Costinean, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|May 24, 2017
Comparative study of receptor discordance between primary and corresponding metastatic lesions in breast cancerGokmen U Erdem, Kadri Altundag, Nuriye Y Ozdemir, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 30, 2016
Correlation of educational status and clinicopathological characteristics of breast cancer: a single center experienceFurkan Sarici, Taner Babacan, Hakan Buyukhatipoglu, et al.
Tumori|May 9, 2015
Efficacy of capecitabine monotherapy as the first-line treatment of metastatic HER2-negative breast cancerTaner Babacan, Orhan Efe, Ahmet S Hasirci, et al.
Journal of the National Medical Association|May 30, 2008
Characteristics of breast cancer patients with central nervous system metastases: a single-center experienceHakan Harputluoglu, Omer Dizdar, Sercan Aksoy, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|December 24, 2014
Outcome of 561 non-metastatic triple negative breast cancer patients: multi-center experience from TurkeyBurcin Budakoglu, Kadri Altundag, Sercan Aksoy, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 19, 2008
Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonatesAna O Hoff, Béla B Toth, Kadri Altundag, et al.
Pageof 16